tallózása szerző szerint "Knoll, József"

1-3 / 3

A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain

Knoll, József; Baghy, Kornélia; Eckhardt S; Ferdinandy, Péter; Garami, Miklós; Hársing, László Gábor; Hauser, Péter; Mervai, Zsolt; Pócza, Tímea; Schaff, Zsuzsa; Schuler, Dezső; Miklya, Ildikó (2017)

AIMS: First proof to show that (-)-deprenyl/selegiline (DEP), the first selective inhibitor of MAO-B, later identified as the first beta-phenylethylamine (PEA)-derived synthetic catecholaminergic activity enhancer (CAE) ...
Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP)

Knoll, József; Miklya, Ildikó (2016)

AIMS: The first longevity study demonstrating that rats treated with the MAO-B inhibitory dose of (-)-deprenyl (0.25mg/kg) lived significantly longer than their saline-treated peers was published in 1988, and corroborated ...
Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response

Knoll, József; Zelena, Dóra; Timár, Júlia; Baghy, Kornélia; Mervai, Zsolt; Miklya, Ildikó (2020)

1-3 / 3

Keresés